Peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine

Neurological Research

Volumn 29, Issue SUPPL. 1, 2007, Pages

  Lee, Byung Cheol ^a   Doo, Ho Kyung ^a   Ahn, Se Young ^a   Byun, Sang Hyuk ^a   Kim, Soon Il ^a   Park, Hun Kuk ^a   Hong, MeeSuk ^a   Ha, Eunyoung ^a   Yim, Sung Vin ^a   Yin, ChangShik ^b   Leem, Kang Hyun ^c   Ahn, Young Min ^a  

^a Kyung Hee University   (South Korea)

^b CHA University   (South Korea)

^c Semyung University   (South Korea)

Author keywords

Ischemic stroke; Peroxisome proliferator activated receptor gamma; Polymorphism; Sasang constitutional medicine

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOTHESIS; KOREA; KOREAN TRADITIONAL MEDICINE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SASANG MEDICINE; SOEUMIN CONSTITUTIONAL MEDICINE; SOYANGIN CONSTITUTIONAL MEDICINE; STATISTICAL SIGNIFICANCE; TAEEUMIN CONSTITUTIONAL MEDICINE; TAEYANGIN CONSTITUTIONAL MEDICINE; TRADITIONAL MEDICINE;

AGED; ALANINE; CEREBROVASCULAR ACCIDENT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MEDICINE, ORIENTAL TRADITIONAL; MIDDLE AGED; PHILOSOPHY, MEDICAL; POLYMORPHISM, GENETIC; PPAR GAMMA; PROLINE;

EID: 33947584071     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X172347     Document Type: Article

References (24)

1. Lee JM. Longevity and Life Preservation in Oriental Medicine, Seoul: Kyung Hee University Press, 1996
2. Chae H, Lyoo IK, Lee SJ, et al. An alternative way to individualized medicine: Psychological and physical traits of Sasang typology. J Altern Complement Med 2003; 9: 519-528
3. Um JY, Joo JC, Kim KY, et al. Angiotensin converting enzyme gene polymorphism and traditional Sasang classification in Koreans with cerebral infarction. Hereditas 2003; 138: 166-171
4. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 1999; 20: 649-688
5. Gurnell M. PPARgamma and metabolism: Insights from the study of human genetic variants. Clin Endocrinol (Oxf) 2003; 59: 267-277
6. Fajas L, Auboeuf D, Raspe E, et al. The organization, promoter analysis, and expression of the human PPARgamma gene. J Biol Chem 1997; 272: 1879-1889
7. Hsueh WA, Bruemmer D. Peroxisome proliferator-activated receptor gamma: Implications for cardiovascular disease. Hypertension 2004; 43: 297-305
8. Kawasaki I, Tahara H, Emoto M, et al. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma 2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects. Osaka City Med J 2002; 48: 23-28
9. Bluher M, Paschke R. Analysis of the relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance. Exp Clin Endocrinol Diabetes 2003; 111: 85-90
10. Pihlajamaki J, Vanhala M, Vanhala P, et al. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood. Obes Res 2004; 12: 187-190
11. Ridker PM, Cook NR, Cheng S, et al. Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. Arterioscler Thromb Vasc Biol 2003; 23: 859-863
12. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80
13. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002; 51: 2341-2347
14. Yen CJ, Beamer BA, Negri C, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 misdense mutation. Biochem Biophys Res Commun 1997; 241: 270-274
15. Herrmann SM, Ringel J, Wang JG, et al. Berlin Diabetes Mellitus (BeDiaM) Study. Peroxisome proliferator-activated receptor-gamma 2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 2002; 51: 2653-2657
16. Ostgren CJ, Lindblad U, Melander O, et al. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism and the association with blood pressure in type 2 diabetes: Skaraborg hypertension and diabetes project. J Hypertens 2003; 21: 1657-1662
17. Joseph KK. Compass of Health: Using the Art of Sasang Medicine to Maximize Your Health, Franklin Lakes, NJ: The Career Press, 2001
18. Oh EY, Min KM, Chung JH, et al. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab 2000; 85: 1801-1804
19. Lee BC, Ahn SY, Doo HK, et al. Susceptibility for ischemic stroke is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor- genes, but not the interleukin-1 gene. Neurosci Lett 2004; 357: 33-36
20. Kim SH, Koh BH, Song IB. A study on the standardization of QSCC II. J Constitut Med 1996; 8: 187-246
21. Koh BH, Kim SH, Park BG, et al. A study on the Sasang constitutional distribution among the people in the United States of America. J Constitut Med 1999; 11: 119-150
22. Song YM, Sung J, Davey Smith G, et al. Body mass index and ischemic and hemorrhagic stroke: A prospective study in Korean men. Stroke 2004; 35: 831-836
23. Tai ES, Corella D, Deurenberg-Yap M, et al. Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population. J Lipid Res 2004; 45: 674-685
24. Lei HH, Chen MH, Yang WS, et al. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese. Metabolism 2000; 49: 1267-1270